Radiation Therapy Quality Assurance Phantoms Market to be dominated by Cobalt-60, through 2028
The increasing prevalence of cancer is expected to
drive the growth of global Radiation Therapy Quality Assurance Phantoms in the
forecast period, 2024-2028.
According to TechSci Research report, “Radiation Therapy Quality Assurance
Phantoms Market
- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028” Global Radiation Therapy Quality
Assurance Phantoms Market is anticipated to grow at an impressive rate in the
forecast period, 2024-2028. This can be ascribed to the increasing demand
for phantoms for the treatment of cancer along with the severe prevalence of
cancer across the globe. Additionally, increasing demand for better treatment
and increasing burden of different types of cancers like head and neck,
prostate, and lung cancer especially in the developed countries in North
America and Europe is expected to create lucrative opportunities for market
growth in coming years. Besides, increasing research and development activities
in the healthcare industry is further expected to support market growth.
Similarly, the growing demand for tissue equivalent phantoms for the treatment
of skin cancer is anticipated to boost the market growth during the forecast
period. Also, the growing demand for precise calibration techniques for
efficient diagnostic imaging procedures along with advancement in radiation
therapy such as image-guided and intensity-modulated radiation therapy will
further boost the market growth over the years.
However, the high
cost of phantoms along with the lack of skilled professionals slowed down the
growth of The Global Radiation Therapy Quality Assurance Phantoms Market in the
forecast period. Similarly, high risks and complications associated with
radiation treatments may hamper the Radiation Therapy Quality Assurance
Phantoms market growth during the forecast period.
Browse over XX market data
Figures spread through XX
Pages and an in-depth TOC on "Radiation Therapy Quality Assurance Phantoms Market"
The global radiation therapy
quality assurance phantoms market can be segmented by technology, therapy,
application, and by region.
Based on technology, the global radiation therapy
quality assurance phantoms market can be segmented into Linear
Accelerators, Cobalt-60, High-Dose Radiation, and Low-Dose Radiation. The cobalt-60 segment dominated the market in
2022 and is expected to continue maintaining its dominance throughout the
forecast period. This can be ascribed to the increasing demand for high-dose
radiation for the diagnosis of cancer and used to control the level of radiation
and kill the malignant cells in tumor and cancer treatment. High efficiency and
increasing usage of clotrimazole drug for the treatment of acute vulvovaginal
candidiasis disease.
Based on therapy, the market can be segmented
into Photon Beam Radiation Therapy, Advanced 3-D Conformal Radiation
Therapy, Image Guided Radiation Therapy, Intensity-modulated radiation therapy,
Volumetric Modulated Arc Therapy, Intraoperative Radiotherapy, Neutron Beam
Therapy, and Brachytherapy.
The brachytherapy segment is expected to dominate during the forecast period on
account of increasing demand for fast treatment of different types of cancers
like prostate, head and neck, cervix, and eye cancers and use for depth of
penetration, distance, etc. in surgery times.
Major companies operating in the global radiation
therapy quality assurance phantoms market are:
- Computerized Imaging Reference Systems, Inc.
- Fluke Biomedical LLC.
- IBA Dosimetry Gmbh.
- Modus Medical Devices Inc.
- PTW Freiburg GmbH.
- Standard Imaging Inc.
- Sun Nuclear Corporation.
- The Phantom Laboratory Inc.
- Gammex Inc.
- Gold Standard Phantoms Limited
UF Radiation Oncology celebrated the
unveiling of its 1.5-Tesla MRI-guided linear accelerator, the Elekta Unity, on
July 21. The Unity will welcome its first patients at the end of the month. The
1.5-T MR-Linac allows us to visualize changes in the tumor or tumors with each
daily treatment precisely delivered.
In October 2020, the Netherlands Cancer
Institute - Antoni van Leeuwenhoek Hospital and PTW Freiburg GmbH signed an
agreement to collaborate on developing an advanced EPID-based dosimetry
solution for automated patient-specific quality assurance during radiotherapy
treatment.
Download Free Sample Report
Customers can also request for 10% free customization on this report.
“North
America is expected to dominate in The Global Radiation Therapy Quality Assurance
Phantoms Market on account due to increasing the number of major medical
technology companies across the region. Furthermore, increasing the usage of
radiotherapy units along with a growing focus on the development of novel
technologies and systematic radiation therapy for providing better patient care,
growing partnerships and collaboration with the gamma knife manufacturers is
further contributing to the demand for Radiation Therapy Quality Assurance Phantoms.
Besides, the availability of skilled professionals and early adoption of
advanced treatments for different types of cancers in the region and the
development of more effective methods for error reduction and process analysis
such as failure mode for dose mistakes and effect analysis is further expected
to create lucrative opportunities for market growth during the forecast period
2028” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based
global management consulting firm.
“Radiation Therapy Quality Assurance Phantoms Market - Global Industry
Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented By Technology (Linear Accelerators, Cobalt-60, High-Dose
Radiation, Low-Dose Radiation), By Therapy (Photon Beam Radiation Therapy,
Advanced 3-D Conformal Radiation Therapy, Image Guided Radiation Therapy,
Intensity-modulated radiation therapy, Volumetric Modulated Arc Therapy,
Intraoperative Radiotherapy, Neutron Beam Therapy, Brachytherapy), By Application
(Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Head, and Neck Cancers,
Skin Cancer, Other) and
By Region”, has
evaluated the future growth potential of global radiation therapy quality assurance
phantoms market and provides statistics & information on market size,
structure, and future market growth. The report intends to provide cutting-edge
market intelligence and help decision-makers take sound investment decisions.
Besides, the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in the global radiation therapy
quality assurance phantoms market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com